|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Cash flow from operating activities | |||
| Net increase (decrease) in net assets resulting from operations | |||
| Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities: | |||
| Accrued interest and dividends received in-kind | |||
| Net accretion of discount and amortization of premium | |||
| Proceeds from sale of investments and principal repayments | |||
| Purchases of investments | |||
| Net realized (gains) losses on investments | |||
| Net change in unrealized (appreciation) depreciation on investments | |||
| Net receipt of settlement of derivatives | |||
| Net realized (gains) losses on derivatives | |||
| Net change in unrealized (appreciation) depreciation on foreign currency forward contracts | |||
| Amortization of deferred financing costs | |||
| Amortization of discount on debt | |||
| (Increase) decrease in operating assets: | |||
| Interest and dividends receivable | |||
| Principal receivable | |||
| Prepaid expenses and other assets | |||
| Increase (decrease) in operating liabilities: | |||
| Due to affiliates | |||
| Payable for investments purchased | |||
| Management fees payable | |||
| Income based incentive fee payable | |||
| Capital gains incentive fee payable | |||
| Interest payable | |||
| Accrued professional fees | |||
| Accrued expenses and other liabilities | |||
| Net cash provided by (used in) operating activities | |||
| Cash flow from financing activities | |||
| Proceeds from issuance of common shares | |||
| Proceeds from issuance of common shares (net of change in subscriptions receivable) | |||
| Proceeds from repurchase obligations | |||
| Repayment of repurchase obligations | |||
| Debt borrowings | |||
| Debt repayments | |||
| Distributions paid | |||
| Deferred financing costs paid | |||
| Proceeds from issuance of preferred shares, net of underwriting costs | |||
| Preferred dividends paid | |||
| Preferred share redemption | |||
| Net cash provided by (used in) financing activities | |||
| Net increase in cash, cash equivalents, and restricted cash | |||
| Cash, cash equivalents, and restricted cash, beginning of period | |||
| Cash, cash equivalents, and restricted cash, end of period | |||
| Supplemental disclosure of cash flow information and non-cash financing activities | |||
| Cash paid for interest | |||
| Reinvestment of shareholder distributions | |||
| Incremental financing cost payable | |||
| Reconciliation of cash, cash equivalents, and restricted cash | |||
| Cash and cash equivalents | |||
| Restricted cash |
Loading...